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Nkx2.1 regulates the generation 
of telencephalic astrocytes during 
embryonic development
Shilpi Minocha1,*, Delphine Valloton1,*, Yvan Arsenijevic2, Jean-René Cardinaux3, 
Raffaella Guidi3, Jean-Pierre Hornung1 & Cécile Lebrand1
The homeodomain transcription factor Nkx2.1 (NK2 homeobox 1) controls cell differentiation of 
telencephalic GABAergic interneurons and oligodendrocytes. Here we show that Nkx2.1 also regulates 
astrogliogenesis of the telencephalon from embryonic day (E) 14.5 to E16.5. Moreover we identify the 
different mechanisms by which Nkx2.1 controls the telencephalic astrogliogenesis. In Nkx2.1 knockout 
(Nkx2.1−/−) mice a drastic loss of astrocytes is observed that is not related to cell death. Further, in vivo 
analysis using BrdU incorporation reveals that Nkx2.1 affects the proliferation of the ventral neural 
stem cells that generate early astrocytes. Also, in vitro neurosphere assays showed reduced generation 
of astroglia upon loss of Nkx2.1, which could be due to decreased precursor proliferation and possibly 
defects in glial specification/differentiation. Chromatin immunoprecipitation analysis and in vitro  
co-transfection studies with an Nkx2.1-expressing plasmid indicate that Nkx2.1 binds to the promoter 
of glial fibrillary acidic protein (GFAP), primarily expressed in astrocytes, to regulate its expression. 
Hence, Nkx2.1 controls astroglial production spatiotemporally in embryos by regulating proliferation of 
the contributing Nkx2.1-positive precursors.
Proper forebrain development is carried out by a series of coordinated and regulated events involving controlled 
cell proliferation, differentiation, and guided migration of neuronal and glial cells. Several spatiotemporally 
orchestrated molecular mechanisms underlie the successful patterning of the telencephalon1–7. Both dorsal and 
ventral telencephalic regions are demarcated by specific gene expression patterns that then generate defined neu-
ronal and glial populations. Dorsal progenitors express homeobox genes of the empty spiracles (Emx1/Emx2) 
and paired homeobox (Pax6) families, and the atonal-related genes Neurogenin (Neurog) 1/Neurog2, whereas 
the ventral progenitors are known to express homeobox genes of the Nkx (Nkx2.1) and distal-less (Dlx1/Dlx2) 
families, Gsh1/2, and achaete-scute-related gene Ascl18–12.
Broadly, amongst the neuronal populations, the glutamatergic projection neurons are generated by dorsal tel-
encephalic progenitors while the GABAergic (γ -aminobutyric acidergic) interneurons originate from the ventral 
telencephalic progenitors3,13–15. Among the glial populations, embryonic oligodendrocytes are produced in waves 
from the ventral telencephalic progenitors16,17. On the other hand, the exact timing of the generation and origin of 
the embryonic astroglial population is still a topic of active investigation. Since the astroglia play essential roles in 
guidance of forebrain commissures during embryonic brain development, a detailed understanding of the points 
of origin and exact timing of generation of the telencephalic astroglia is essential. In the ventral telencephalon, 
our and other reports have shown that early embryonic astrocytes are generated from ventral bipotential radial 
glia18,19. In the dorsal telencephalon, especially the cerebral cortex, astrocyte gliogenesis has been documented 
to occur only after neurogenesis (after E17 in mice), when the bipotential radial glial cells of the dorsal pallium 
differentiate into glia precursors or astrocytes20–29. Dorsal midline astroglia in the corpus callosum (CC), glial 
wedge (GW) and indusium griseum (IG) have also been shown to originate from the radial glia of the dorso-
medial pallium30,31. However, the time of generation of some of the astrocytes occupying the CC and adjacent 
regions is noted to be between E13 and postnatal day 2 (P2), with a peak at E14, much earlier than previously 
proposed30. Later, the postnatal astrocytes that occupy the cerebral cortex region are believed to also originate 
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from progenitor cells in the dorsolateral subventricular zone (SVZ)32,33. Recent evidence, however, shows that a 
population of locally differentiated glia in the postnatal cortex rather constitute the primary source of astrocytes34.
Nkx2.1, a homeodomain transcription factor, was initially found to regulate the transcription of many thy-
roid35–37 and lung-specific genes38,39. Interestingly, Nkx2.1 regulates several cell cycle related genes such as Notch1, 
E2f3, Cyclin B1, Cyclin B2 and c-Met in developing embryonic lungs40. In the embryonic brain, Nkx2.1 controls 
the specification of the GABAergic interneurons and oligodendrocytes that populate the ventral and dorsal telen-
cephalic region3,16,37,41–43. Loss of Nkx2.1 leads to ventral-to-dorsal re-specification of the pallium causing loss of 
GABAergic interneurons and oligodendrocytes in the dorsal telencephalic region16,17,37. Recently, we showed that 
Nkx2.1 regulates the generation of astrocytes that populate the ventral telencephalon during embryonic devel-
opment and participates in axonal guidance in the anterior commissure18,44. We found that this Nkx2.1-derived 
astrocyte population is generated from three ventral telencephalic precursor regions, namely the medial gangli-
onic eminence (MGE), the anterior entopeduncular area (AEP)/preoptic area (POA) and the triangular septal 
nucleus (TS)18,44. Several works have revealed information on the origin of embryonic NG2 glia, also known as 
polydendrocytes or oligodendrocyte precursor cells45,46. Our work contributed by showing that embryonic NG2 
glia originate from the Nkx2.1+ progenitors of the ventral telencephalon and promote precise blood vessel net-
work development44. These cells have a highly complex branched morphology and are different from neurons, 
mature oligodendrocytes, astrocytes and microglia45–52. For a clear distinction, these cells will be referred to as 
“NG2 glia” in this study.
Here, we describe that Nkx2.1-derived astrocytes populate the corpus callosum (CC) and its surrounding 
regions in the embryonic dorsal telencephalon. These Nkx2.1-derived astrocytes are generated from E12.5 
onwards with maximal production between E14.5 to E16.5. Interestingly, in Nkx2.1−/− mice, we showed that the 
mutated Nkx2.1 (mut-Nkx2.1) leads to a drastic loss of astrocytes and NG2 glia in the dorsal telencephalic region 
at the midline. Since this mut-Nkx2.1 derived cell loss is not accompanied by increased cell death, we analyzed 
if cell proliferation of Nkx2.1+ progenitors in the three ventral precursor regions (MGE, AEP/POA and TS) 
was affected. In vivo BrdU incorporation showed that interestingly Nkx2.1 regulates astroglial generation by 
controlling the proliferation of Nkx2.1+ precursors. Similarly, in vitro neurosphere differentiation assays showed 
decreased generation of astroglia from Nkx2.1−/− precursors, which may be a result of decreased proliferation of 
astroglial precursors upon loss of Nkx2.1 or perhaps defects in glial specification and/or differentiation. In addi-
tion, chromatin immunoprecipitation analysis showed that Nkx2.1 binds to the promoter of the glial fibrillary 
acidic protein (GFAP), primarily expressed in radial glia and astroglia. Co-transfection studies in HEK293 cells 
using tagged over-expressed Nkx2.1 and a mouse GFAP promoter construct confirmed that Nkx2.1 binds to the 
GFAP promoter and regulates expression of the GFAP gene. Thus, Nkx2.1 exhibits multilevel control over the 
generation of the dorsal telencephalic astroglia by spatially coordinating astroglial generation from three ventral 
precursor regions and temporally restricting maximal generation to E14.5 to E16.5. Further analysis into the 
complete repertoire of genes regulated by Nkx2.1 will shed light on the exact mode of action and help to delineate 
the different mechanisms involved in astrogliogenesis.
Results
Nkx2.1-derived astrocytes populate the dorsal telencephalon during development. Nkx2.1-
positive (Nkx2.1+) progenitors of the MGE, AEP/POA and septal nucleus generate embryonic GABAergic 
interneurons and oligodendrocytes that populate the ventral and dorsal telencephalon3,16,37,41–43. Our recent 
results have shown that Nkx2.1 additionally regulates the production of astrocytes and NG2 glia that populate the 
ventral telencephalon18,44. Further immunostaining of the subpallial transcription factor Nkx2.1 revealed strong 
expression in several differentiated cells within and around the CC in the dorsal telencephalon from E16.5 to 
E18.5 (n = 8; Fig. 1a–g). To differentiate the Nkx2.1+ cell types in the CC region we made use of several cell-type-
specific transgenic strains.
To identify the GABAergic interneurons, we used Gad1 (Glutamate decarboxylase 1; also called as 
GAD67)-EGFP knock-in mice that express the enhanced green fluorescent protein (EGFP) in GAD67+ 
GABAergic interneurons53. In combination with Nkx2.1, as with previous observations, we show down-regulation 
of Nkx2.1 expression in dorsal telencephalic GABAergic interneuron population54 at E16.5, and also observe that 
none of the Gad1-GFP+ interneurons of the CC and dorsal surrounding areas express Nkx2.1 (n = 4; Fig. 1a,b; 
solid arrowheads in 1b).
To ascertain that Nkx2.1+ cells corresponded to NG2 glia, we made use of the Cspg4 (Chondroitin sulfate 
proteoglycan 4)-Cre+/Rosa-EYFP mice that express the enhanced yellow fluorescent protein (EYFP) in NG2+ 
(Neuron-glial antigen 2) glia44–46. We found that EYFP was expressed by Nkx2.1+ progenitors of the MGE (n = 3; 
Supp. Fig. S1a-c, solid arrowheads in b-c). However, the EYFP+ NG2 glia did not express the Nkx2.1 protein out-
side ventral germinal zones nor within the dorsal telencephalon (n = 3; Supp. Fig. S1g-i, open arrowheads in h-i). 
To further delineate the profile of Nkx2.1+ cells in the CC and the surrounding areas, we performed immu-
nostaining against Nestin and GLutamate and ASpartate Transporter (GLAST), specific for post-mitotic astro-
cytes within the embryonic CC white matter30. Interestingly, from E16.5 to E18.5, 60% (n = 6) of the GLAST+ 
astrocytes cells of the CC and surrounding regions were found to be Nkx2.1+ (n = 11; Figs 1c,d,f,g and 3a,b,e, 
Supp. Fig. S1h-i, solid arrowheads). After postnatal day 0 (P0) however, Nkx2.1 was strongly down-regulated and 
not detected anymore in the astrocytes of the dorsal telencephalon (n = 8, not shown). Nkx2.1 expression was 
never detected in radial glial precursor cells of the glial wedge nor of the dorsal telencephalic ventricular zone 
detected by the aforementioned astrocytic markers (n = 11; Supp. Fig. S2 a-b).
Further analyses using tamoxifen-inducible GLAST-Cre ERTTM/Rosa26-EYFP mice displayed the presence 
of many EYFP+ early astrocytes outside of the germinal zones and also within the CC and surrounding area 
from E16.5 to E18.5 (n = 5; Fig. 1e–j). Many of these early astrocytes visualized by EYFP and GLAST co-staining 
showed Nkx2.1 expression also (n = 5; CC in Fig. 1f,g and MGE in 1i-j, solid arrowheads).
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Figure 1. The Nkx2.1-positive cells of the CC are astroglial cells. (a–d) Double immunohistochemistry on 
coronal CC sections from Gad1-EGFP+ mice at E16.5 for GFP and Nkx2.1 (a,b) (n = 4), and on coronal CC 
sections from wild-type mice at E16.5 for GLAST and Nkx2.1 (c,d) (n = 2). (e–j) Triple immunohistochemistry 
for EYFP, Nkx2.1 and GLAST on coronal CC (e-g) and MGE (h–j) sections from GLAST-Cre:ERT2+/Rosa-
EYFP mice at E18.5 (n = 5). Colocalization in the green and the red channels is yellow (b,c,d,f,i and j). (b), (d), 
(f), (g), (i), and (j) are higher magnifications of the CC and MGE region indicated by an arrow in (a), (c), (e) 
and (h), respectively. Cell nuclei were counterstained in blue with Hoechst (a,e, and h). (a–d) At E16.5, several 
Nkx2.1+ (red) nuclei were observed in the medial part of the CC (open arrowheads in b). Nkx2.1 did not label 
the Gad1-EGFP+ interneurons (green) populating this region (solid arrowhead in b). At this age, however, most 
of the Nkx2.1-expressing nuclei co-expressed astroglial markers like GLAST (solid arrowheads in c and d).  
Quantification shows that 60% of E16.5 GLAST+ cells are Nkx2.1+ at E16.5 (n = 3) and at E18.5 (n = 3).  
(e–j) The Cre-mediated recombination was initiated by inducing the tamoxifen-inducible GLAST promoter at 
E14, and the GLAST-derived astroglia were visualized (in green) with the EYFP signal shown in e,f and  
h,i,j. Some GLAST+ astroglial cells (in light blue) in the CC (e–g) and the MGE (i,j) co-expressed Nkx2.1 (in 
red, solid arrowheads). Some of the GLAST+/Nkx2.1+ glia were not labeled by the EYFP signal and might 
have been generated before recombination was induced (open arrowheads in f and g). (CC) corpus callosum; 
(CCi) cingulate cortex; (IG) induseum griseum; (HIC) hippocampal commissure; (MGE) medial ganglionic 
eminence; (RMS) rostral migratory stream; (SEP) septum; (TS) triangular septal nucleus. Bar = 675 μ m in  
(e) and (h); 450 μ m in (a); 67 μ m in (b) and (c); 40 μ m in (f), (g), (i) and (j); 30 μ m in (d).
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Therefore, the previous and current extensive immunohistochemical analyses in combination with differ-
ent transgenic strains reveals that the CC and surrounding regions are populated with various Nkx2.1-derived 
glial cell types (summarized in Fig. 2)18. Presence or absence of Nkx2.1 protein expression primarily divides the 
Nkx2.1-derived glial classes into two major subtypes in both the dorsal and ventral telencephalon: astrocyte-like 
or polydendrocyte-like (or NG2 glia). The Nkx2.1-derived astrocyte-like population is further sub-divided 
into two populations: GLAST+/GFAP+/Nkx2.1+ (orange) and GLAST+/GFAP-/Nkx2.1+ (green) (Fig. 2 and 
Supp. Fig. S3). The polydendrocyte-like population (or NG2 glia) is also further sub-divided into two popula-
tions: NG2+/Olig2+/S100β +/Nkx2.1− (red) and NG2+/Olig2+/S100β −/Nkx2.1− (brown) populations (Fig. 2 and 
Supp. Fig. S3). Interestingly, a subpopulation of the GLAST+ astrocyte-like population within the telencephalon 
(blue) is not Nkx2.1-derived and expresses Olig2 (n = 4; Fig. 2; Fig. 3a,b and e)18.
Nkx2.1-derived astrocyte-like cells populate the CC region towards the end of the embryonic period. Use of 
tamoxifen-inducible GLAST-Cre ERTTM/Rosa26-EYFP mice showed several Nkx2.1+/GLAST+/EYFP+ astrocytes 
beginning from E14.5 onwards as tamoxifen was delivered at E14.5 (n = 5; Fig. 1e–g). To decipher the exact tim-
ing of generation of these Nkx2.1+ glial cells in the CC region, we administered 5-bromo-2′ -deoxyuridine (BrdU) 
to wild-type (WT) pregnant females at E12.5 (n = 2), E14.5 (n = 2), and E16.5 (n = 2), and analyzed BrdU incor-
poration at E18.5 in CC astrocytes co-expressing Nkx2.1 and GLAST or GFAP (Fig. 4). Combined immunostain-
ing revealed a few BrdU+/Nkx2.1+/GLAST+and BrdU+/GFAP+ embryonic astrocytes in the CC when BrdU was 
Figure 2. Four subtypes of Nkx2.1-derived glial cells. The schema represents a coronal view of the CC 
at E18.5 and summarizes the four different subtypes of Nkx2.1-derived glial populations visualized in our 
experiments. The CC forms a complex environment composed of one non-Nkx2.1-derived astroglial cell 
subtype and four different subtypes of Nkx2.1-derived glial cells. Three types of astrocyte-like cell populations 
are shown: in blue, the non-Nkx2.1-derived GLAST+/Olig2+/Nkx2.1− cells, in orange, the Nkx2.1-derived 
GLAST+/GFAP+/S100β +or−/Olig2−/Nkx2.1+ cells and in green, the Nkx2.1-derived GLAST+/GFAP−/S100β −/
Olig2−/Nkx2.1+ cells. Two types of Nkx2.1-derived polydendrocyte-like cells (also called NG2 glia) are shown; 
in red, the GLAST−/S100β +/NG2+/Olig2+/Nkx2.1− cells, and in brown, the GLAST−/S100β −/NG2+/Olig2+/
Nkx2.1− cells. Under each glial cell-type picture, the expression profile of the different glial markers tested to 
characterize the glial cells, used in combination with the Nkx2.1 antibody, is presented. The (+) sign indicates 
that the glial cell type was labeled by the listed marker and the (–) sign indicates that the glial cell type was not 
labeled by the listed marker. (CCi), cingulate cortex; (CFr) frontal cortex; (CPa) parietal cortex; (SEP) septum.
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delivered at E12.5 (Fig. 4a–c and j, solid arrowheads). The bulk of the BrdU+/Nkx2.1+/GLAST+ (33% at E14.5 
and 45% at E16.5) and BrdU+/GFAP+ (60% at E14.5 and 70% at E16.5) embryonic astrocytes were observed when 
BrdU was delivered at E14.5 (Fig. 4d–f and k, solid arrowheads) and E16.5 (Fig. 4h,i and l, solid arrowheads) indi-
cating that the majority of Nkx2.1-derived astrocytes in the CC region are produced between E14.5 and E16.5.
The results indicate that Nkx2.1 expression is primarily maintained in the astrocyte population of the CC 
region from E14.5 to E18.5.
Nkx2.1 controls gliogenesis in the embryonic telencephalon. To further investigate the function 
of Nkx2.1 in regulating embryonic gliogenesis, we performed immunohistochemistry at E18.5 for astroglia and 
NG2 glia markers in control and Nkx2.1−/− embryos expressing an inactivated truncated Nkx2.1 (mut-Nkx2.1) 
Figure 3. Loss of GLAST+/Olig2− astroglia and GLAST−/Olig2+ NG2 glia in the CC of Nkx2.1−/− mutant 
mice. (a–d) Double immunohistochemical staining with Olig2 and GLAST on CC coronal sections from: 
controls (Ctl), Nkx2.1+/+ and Nkx2.1+/− (n = 4) (a,b), and Nkx2.1−/− (n = 2) (c,d) mice at E18.5. Cell nuclei 
were counterstained in blue with Hoechst (a–d). (b) and (d) are higher magnifications of the CC of (a) and 
(c), respectively. (b and d). In the CC midline of Nkx2.1−/− mice, there was a severe loss of GLAST+/Olig2− 
astroglia (arrows) and GLAST−/Olig2+ NG2 glia (open arrowheads) but not of GLAST+/Olig2+ astroglia 
(solid arrowheads), compared to the control mice. (e) Bars (mean ± SEM from a sample of n = 3 control (Ctl) 
and n = 3 Nkx2.1−/− mice) represent the density (number of cells/mm3) of GLAST+/Olig2−, GLAST−/Olig2+ 
and GLAST+/Olig2+ glial cells in the CC of Nkx2.1−/− knockouts (KO) compared to Ctl mice at E18.5. The 
quantification confirms the significant decrease in GLAST+/Olig2− astroglia (p-value = 0.0297) and GLAST−/
Olig2+ NG2 glia (p-value = 0.0242) and no change in GLAST+/Olig2+ astroglia (p-value = 0.4469) in the 
Nkx2.1−/− CC compared to control CC. (CC) corpus callosum; (CCi) cingulate cortex; (CI) cingulate bundle. 
Bar = 675 μ m in (a) and (c); 100 μ m in (b) and (d).
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(Fig. 5). As controls we used both homozygous (Nkx2.1+/+) and heterozygous (Nkx2.1+/−) mice. In control mice, 
GLAST+ (n = 2) or GFAP+ (n = 4) astroglia, and NG2+ glia (n = 5) were clearly visible in the CC and surround-
ing regions, in the medial cortical area as well as in the septum (SEP) (Fig. 5a–c and e,f, respectively). In contrast 
Figure 4. Nkx2.1-positive astroglia of the CC are generated between E14.5 and E16.5. (a–i) Triple 
immunohistochemistry with Nkx2.1, 5-bromo-2′ -deoxyuridine (BrdU), and GLAST, and (j–l) double 
immunohistochemistry with BrdU and GFAP on corpus callosum (CC) coronal sections from wild type 
brains injected at E12.5 (n = 2) (a–c and j), E14.5 (n = 2) (d–f and k) and E16.5 (n = 2) (g–i and l).  
(a–i) At E18.5, several GLAST+ astroglial cells (green) expressing Nkx2.1 (red) are present in the CC 
midline. (b,e and h) Colocalization between the blue (BrdU) and the red (Nkx2.1) channel is observed in 
yellow. (c,f and i) Colocalization between the green (GLAST) and the red (Nkx2.1) channel is observed in 
yellow. The solid arrowheads show the Nkx2.1+/GLAST+/BrdU+ cells revealing that the bulk of division 
for the Nkx2.1+ astroglial cells of the CC occurs between E14.5 (e) and E16.5 (h). Quantification indicates 
that the fraction of Nkx2.1+/GLAST+ glia that show BrdU labeling at E18.5 is 4% when BrdU injections 
are performed at E12.5, 33% when BrdU injections are performed at E14.5, and 45% when BrdU injections 
are performed at E16.5. (j–l) Numerous GFAP+ astroglial cells (in green) are present in the CC midline. 
Colocalization between the green (GFAP) and the red (BrdU) channel is observed in yellow. The solid 
arrowheads signify GFAP+/BrdU+ cells indicating that main division of GFAP+ glial cells in the CC occurs 
also from E14.5 (k) to E16.5 (l). Quantification indicates that the fraction of GFAP+ glia that show BrdU 
labeling at E18.5 is 33% when BrdU injections are performed at E12.5, 60% when BrdU injections are 
performed at E14.5, and 70% when BrdU injections are performed at E16.5. Bar = 60 μ m in (a–l).
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we observed a drastic loss (70 to 100%) of astroglia (n = 2 stained for GLAST; n = 3 stained for GFAP) and NG2 
glia (n = 4) in all midline dorsal regions in Nkx2.1−/− mice (Fig. 5g–i and k,l). However, Nkx2.1 inactivation did 
not affect the number and organization of radial glia within the GW as expected for glial cells that do not express 
Nkx2.1 (compare Fig. 5a,b and g,h). Quantitative measurements with the astrocyte marker, GLAST (Fig. 5m), 
GFAP (Fig. 5n) and NG2 (Fig. 5o) confirmed the severe loss of astroglia and NG2 glia in the midline dorsal 
telencephalic areas in Nkx2.1−/− mice. There was a particularly high loss of GLAST+ and GFAP+ astrocytes in 
the CC and surrounding areas (indusium griseum, IG and midline zipper glia, MZG) in the Nkx2.1−/− embryos 
(n = 3) compared to control embryos (n = 4) (p-value < 0.05 for CC, IG and MZG, Fig. 5m and n). Interestingly, 
GFAP labeling also revealed the loss of a subpopulation of GFAP+ radial glial precursors within the ventral tel-
encephalon, in the mutant-MGE (MGE*; mutant precursor regions are denoted by an additional asterisk37) and 
mutant-POA (POA*) ventricular zone (VZ) of the Nkx2.1−/− embryos (compare Fig. 5d to j, p-value = 0.0496 for 
MGE and 0.0247 for POA; Fig. 5n). Additionally there was a near complete loss (99 to 100%) of NG2 glia in the 
medial cortical areas of Nkx2.1−/− embryos (n = 3) compared to control embryos (n = 5) (p-value = 0.0334 for 
CC medial and 0.0191 for CC lateral; Fig. 5k,l and o).
As we identified different Nkx2.1-derived glial cell populations, Olig2+ or Olig2− astrocytes and Olig2+ NG2 
glia, we further investigated the function of Nkx2.1 in astrogliogenesis in the different glial cell types (Fig. 2). For 
Figure 5. Loss of different glial cell types in the CC, medial cortical areas and subpallium of Nkx2.1−/− mice 
brains. DAB staining with GLAST (n = 4 for Nkx2.1+/+ or Nkx2.1+/− controls (Ctl) and 3Nkx2.1−/−) (a and g),  
GFAP (n = 4 for Ctl and 3 for Nkx2.1−/−) (b–d and h–j) and NG2 (n = 5 for Ctl and n = 4 for Nkx2.1−/−) (e,f 
and k,l) on CC and MGE coronal sections from controls (Ctl) Nkx2.1+/+ or Nkx2.1+/− (a–f) and Nkx2.1−/− 
(g–l) mice at E18.5. (c), (f), (i) and (l) are higher magnifications of the CC region seen in (b), (e), (h) and (k), 
respectively. (d) and (j) are higher magnifications of the MGE region seen in (b) and (h), respectively. DAB 
staining for GLAST, GFAP and NG2 revealed a drastic loss of astroglial and polydendroglial cell types from 
the CC and surrounding areas and from the MGE of the Nkx2.1−/− mice compared to control mice (compare g 
with a;h,i with b,c;j with d and k,l with e,f). Only the GFAP+ radial glial cells originating from the Nkx2.1− glial 
wedge (GW) bordering the CC remain unaffected (white arrowhead in g and i). (m,n and o) Bars (mean ± SEM 
from a sample of n = 4 brains in Ctl and n = 3 brains in Nkx2.1−/− for GLAST and GFAP and of n = 5 in Ctl and 
n = 3 in Nkx2.1−/− for NG2) represent the cell densities of GFAP+ or NG2+ glial cells/mm2. The quantification 
of the GLAST+ (p-value = 0.0005 for CC, 0.0036 for IG, 0.028 for MZG), GFAP+ (p-value = 0.0056 for CC, 
0.0216 for IG, 0.0067 for MZG, 0.0496 for MGE, and 0.0247 for POA) and NG2+ (p-value = 0.0334 for CC 
medial and 0.0191 for CC lateral) glial cell density showed a drastic and significant loss of these cells in the CC 
and surrounding areas as well as in medial cortical areas of the Nkx2.1−/− brains compared to the Ctl brains. 
(CC) corpus callosum; (CCi) cingulate cortex; (GW) glial wedge; (IG) induseum griseum; (LV) lateral ventricle; 
(MZG) midline zipper glia; (MGE) medial ganglionic eminence; (SEP) septum. Bar = 500 μ m in (b), (e), (h) and 
(k); 250 μ m in (a), (c), (d), (f), (i), (j) and (l); 125 μ m in (f) and (l).
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this, we performed immunostaining with Olig2 and GLAST on telencephalic CC sections from both controls 
(n = 4) and Nkx2.1−/− (n = 2) mice. In the Nkx2.1−/− CC, a significant reduction (around 70%) of GLAST+/
Olig2− astrocytes was observed compared to controls (p-value = 0.0297) while no difference was detected for 
GLAST+/Olig2+ astroglial cell density (p-value = 0.4469) (Fig. 3a–e). The GLAST−/Olig2+ NG2 glia population 
was almost completely lost (around 98%) in the CC (p-value = 0.0242; Fig. 3e). In summary, Nkx2.1 regulates 
both the GLAST+/Olig2– astroglia and GLAST−/Olig2+ NG2 glia but not the GLAST+/Olig2+ astroglia (also 
illustrated in Fig. 2).
To investigate if cell death is the reason for the marked decrease in the number of glial cells observed, we ana-
lyzed the control (n = 4 for CC region; n = 5 for POA region) and Nkx2.1−/− (n = 6 for CC region; n = 10 for POA 
region) brains at E16.5 for presence of cleaved-caspase 3, a key biomarker of apoptosis (Supp. Fig. S4a–d and S4i) 
as well as terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay to 
detect DNA fragmentation that results from different cell death processes (n = 16 for CC in controls, n = 22 for 
CC in knockouts; n = 6 for POA in controls, n = 5 for POA in knockouts; n = 10 for MGE in controls, n = 11 for 
MGE in knockouts; n = 7 for SEP in controls, n = 14 for SEP in knockouts; Supp. Fig. S4e-h and S4j). Hoechst was 
also used to visualize pyknotic nuclei. Quantification of dying cells labeled by cleaved-caspase 3 (Supp. Fig. S4i), 
and by TUNEL staining (Supp. Fig. S4j), revealed no significant differences between the Nkx2.1−/− brains and the 
control brains in any of the telencephalic regions tested namely the CC, MGE, POA or septum (p-value = 0.1225 
for CC and 0.4618 for POA with cleaved caspase 3 staining; p-value = 0.7934 for CC, 0.8193 for POA, 0.4032 for 
MGE, and 0.4879 for SEP with TUNEL assay). The size and morphology of cell nuclei were comparable in both 
control and mutant brains.
In conclusion, glial cells occupying the CC are under the regulation of Nkx2.1. Moreover, the significant loss 
of astrocytes and NG2 glia in the Nkx2.1−/− telencephalon is not due to glial cell death.
Nkx2.1 regulates the proliferation of astrocyte ventral progenitors in embryonic brains. The 
loss of specified glia in Nkx2.1−/− mice may be due to insufficient proliferation of ventral glial Nkx2.1-precursors 
in the progenitor zones, MGE, AEP/POA and TS. We labeled coronal sections of the ventral precursor regions 
in both Nkx2.1+/+ or Nkx2.1+/− controls (n = 4) and Nkx2.1−/− (n = 4) mice brains at E16.5 with Nkx.2.1 and 
radial glia/astrocytic marker, GLAST. Both, the mutated Nkx2.1 (mut-Nkx2.1) and the WT Nkx2.1 proteins are 
similarly recognized by anti-Nkx2.1 antibody indicating that the mutated protein conserves an intact epitope 
sufficient for recognition by the antibody55.
In the VZ, SVZ and mantle zone of the control MGE, many GLAST+ precursors and differentiated astroglia 
co-express Nkx2.1 (Fig. 6a–c and h, solid arrowheads) whereas in the germinal and mantle zones of the mutant 
MGE* in Nkx2.1−/− mice very few GLAST+ precursors and astroglia showed co-localization with the mut-Nkx2.1 
(Fig. 6d–f, solid arrowheads). This difference may be attributed as shown previously, to the fact that although a 
MGE-like structure forms in the mutant (MGE*), it has been re-specified to a more dorsal LGE (lateral ganglionic 
eminence)-like fate38. A similar reduction in cells containing GLAST and mut-Nkx2.1 were seen in the mutant 
POA* of Nkx2.1−/− mice (Fig. 6i,j). Quantitative analysis revealed a very large and significant decrease of the 
total number of precursors (50 to 85%) and specifically GLAST+ precursors (45 to 86%) expressing mut-Nkx2.1 
in the VZ, SVZ of the MGE*, POA* and TS* (p-value < 0.0001 in the VZ of MGE, POA and TS in Fig. 6k,l and 
p-value = 0.0139 for the SVZ of MGE in Fig. 6k). Consequently, the number of GLAST+ differentiated astrocytes 
co-expressing mut-Nkx2.1 in the parenchyma (striatum (ST); lateral preoptic area (LPOA)/Lateral hypothalamus 
(LH); septum (SEP)) in Nkx2.1−/− mice (n = 4) was severely decreased (60 to 80%) compared to control mice 
(n = 4) (p-value < 0.0001 for striatum, LPOA and septum in Fig. 6l). Therefore, mutation of Nkx2.1 results in the 
severe loss of precursors and differentiated astrocytes in the brains.
To test the cell proliferation status of precursors in the germinal zones we used a marker of S-phase, BrdU. The 
rate of cell proliferation was examined in Nkx2.1+/+ (n = 8) or Nkx2.1+/− (n = 3) controls and Nkx2.1−/− (n = 8) 
mice at E16.5 when the bulk of the embryonic telencephalic glia is generated. In the control brains, numerous 
Nkx2.1+ precursors were co-labeled with BrdU in both the VZ and SVZ of the MGE, (Fig. 7a–c, solid arrow-
heads). For quantification, we used n = 4 controls and n = 4 knockouts (Fig. 7g–j). In the mutant MGE* of 
Nkx2.1−/− mice, we quantified significantly less BrdU+ progenitors in the VZ and SVZ compared to the control 
MGE (p-values < 0.001 for MGE-VZ; 0.0064 for MGE-SVZ, 0.235 for STRIATUM; and 0.0126 for LPOA/LH in 
Fig. 7g). Intriguingly, an increased number of total BrdU+ cells were found in the POA* VZ and SVZ regions in 
Nkx2.1−/− mice (p-values < 0.001 for POA-VZ/-SVZ). Nonetheless, BrdU+ precursors only very rarely expressed 
mut-Nkx2.1 in both the mutant MGE* and POA* regions (compare Fig. 7c to f). The number of BrdU+ dividing 
cells labeled with mut-Nkx2.1 was severely reduced (75 to 80%) in the Nkx2.1−/− brains (p-values < 0.0001 for 
MGE-VZ/-SVZ and POA-VZ/-SVZ; 0.0042 for STRIATUM; and 0.3182 for LPOA/LH in Fig. 7h). We also quan-
tified the percentage of Nkx2.1+ and mut-Nkx2.1+ cells co-stained for BrdU. A clear reduction in the percentage 
of mut-Nkx2.1+/BrdU+ proliferating cells was seen in Nkx2.1−/− mice (Fig. 7i). Hence, mutation of Nkx2.1 results 
in the incapacity of the Nkx2.1-derived precursors to divide (p-values < 0.0001 for MGE-VZ/-SVZ;< 0.0005 for 
POA-SVZ; 0.043 for STRIATUM; 0.934 for POA-VZ; and 0.3518 for LPOA/LH in Fig. 7i). In contrast, dividing 
cells that did not express mut-Nkx2.1 in the Nkx2.1−/− brains were either not affected in the mutant MGE* or up 
regulated in the mutant POA* (p-values < 0.0001 for POA-SVZ; 0.0214 for POA-VZ; 0.0796 for MGE-VZ, 0.1503 
for MGE-SVZ; 0.1015 for STRIATUM; and 0.741 for LPOA/LH in Fig. 7j).
Altogether, these observations indicate that the transcription factor Nkx2.1 controls the proliferation step 
of Nkx2.1+ precursors in the MGE and the POA, the subpallial domains that mainly generate early embryonic 
astroglia.
Nkx2.1 regulates the production of Nkx2.1-derived astroglia in embryonic brains. Next, we 
analyzed the in vitro capacity of Nkx2.1+ precursors to generate early astroglial cells by observing the MGE- and 
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POA-derived neurosphere differentiation at E14.5. After 7 days in vitro (DIV), control MGE and POA neuro-
spheres are able to differentiate and generate several brain cell types56 which are GFAP+ (Fig. 8b and e) and 
GLAST+ (Fig. 8c and f) astrocytes as well as ßIII-tubulin+ post-mitotic neurons (not shown). GFAP+ and 
GLAST+ astrocytes were uniformly dispersed over the entire surface of the spheres (Fig. 8a and d). Labeling 
with Nkx2.1 showed that in the neurospheres derived from control MGE and POA, Nkx2.1 was expressed in 
the nucleus of about 50% of the GFAP+ and GLAST+ astroglia (Fig. 8b and g; solid arrowheads). However, 
in vitro differentiation of E14.5 Nkx2.1−/− mutant MGE* and POA*-derived neurospheres revealed that pre-
cursors expressing mut-Nkx2.1 nearly lost the capacity to generate mut-Nkx2.1+/GFAP+ and mut-Nkx2.1+/
GLAST+ astroglia (Fig. 8e–f). Quantification showed that mutation of Nkx2.1 in the MGE* and POA* neuros-
pheres of Nkx2.1−/− induced a significant decrease of mut-Nkx2.1+/GFAP+ and mut-Nkx2.1+/GLAST+ astroglia 
Figure 6. Incapacity of precursor cells to generate astrocytes in the Nkx2.1−/− mouse brain. (a–c and g,h) 
Double immunohistochemical staining with Nkx2.1 and GLAST on MGE (a–c) and POA (g,h) coronal sections 
from Nkx2.1+/+ or Nkx2.1+/− control (Ctl) (n = 4) brains at E16.5 (d–f and i,j) Double immunohistochemical 
staining for mutated-Nkx2.1 (mut-Nkx2.1) and GLAST on MGE* (d–f) and POA* (I,j) coronal sections from 
Nkx2.1−/− (n = 4) brains at E16.5. Cell nuclei were counterstained in blue with Hoechst (a,d,g,h and i,j). (b), 
(c), (e), (f), (h) and (j) are higher magnifications of the regions seen in (a), (d), (g) and (i) respectively.  
(a–c) In the germinal regions of the Ctl MGE, numerous Nkx2.1+ progenitors were GLAST+ (solid arrowheads 
and inset in c), while some were GLAST−(open arrowheads in c). (d–f) In Nkx2.1−/− MGE* germinal regions, 
only few GLAST+ progenitors expressed the mut-Nkx2.1 protein (solid arrowheads and inset in f). (g–h) In 
the parenchyma of Ctl POA, many GLAST+ astroglial cells (solid arrowheads in h) and neurons expressed 
Nkx2.1. (i,j) In the parenchyma of Nkx2.1−/− POA*, GLAST+ astroglial cells expressing the mut-Nkx2.1 protein 
disappeared and only a few neurons expressing mut-Nkx2.1 protein were observed (open arrows in j). (GP) 
globus pallidus; (LGE) lateral ganglionic eminence; (LPOA) lateral POA; (MGE) medial ganglionic eminence; 
(MGE*) mutant MGE; (POA) preoptic area; (POA*) mutant POA; (SEP) septum; (SVZ) subventricular zone; 
(TS) triangular septal nucleus, (VZ) ventricular zone. Bar: 100 μ m in (b) and (e); 45 μ m in (c) and (f) and 50 μ m 
in (h) and (j). (k,l) Bars (mean ± SEM from n = 4 Ctl and n = 4 Nkx2.1−/− brains) represent the percentage of 
Nkx2.1+ cells (k) and Nkx2.1+/GLAST+ precursors and astroglial cells (l) in Ctl (white-columns) and Nkx2.1−/− 
(black-columns) regions at E16.5. (k and l) The number of cells (k) and GLAST+ precursors and post-mitotic 
cells (l) expressing mut-Nkx2.1 were drastically decreased in all the subpallial telencephalic regions of the 
Nkx2.1−/− brains. (k) p-values < 0.0001 for MGE-VZ/-SVZ, POA-VZ/-SVZ, ts-VZ, SEPTUM, < 0.0005 for 
LPOA/LH, and 0.571 for STRIATUM. (l) p-values < 0.0001 for MGE-VZ, STRIATUM, POA-VZ/-SVZ, LPOA/
LH, ts-VZ, SEPTUM and 0.0139 for MGE-SVZ. (***p < 0.001; **p < 0.01; *p < 0.05; Student’s t-test).
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Figure 7. Incapacity of Nkx2.1+ precursor cells to divide after Nkx2.1 inactivation. Double 
immunohistochemical staining with Nkx2.1 and BrdU (a–c) and mut-Nkx2.1 and BrdU (d–f) on telencephalic 
coronal sections from Nkx2.1+/+ or Nkx2.1+/− control (Ctl) (n = 4) (a–c) and Nkx2.1−/− (n = 4)  
(d–f) mice brains at E16.5. Cell nuclei were counterstained in blue with Hoechst (a–f). (b) and (e) are higher-
magnifications of MGE squared regions in (a) and (d), respectively. (c) and (f) are higher-magnifications 
of MGE in b and e, respectively. (a–c) In VZ and SVZ of Ctl MGE, AEP/POA and TS, numerous Nkx2.1+ 
precursors (red) were BrdU+ (light blue) (solid arrowheads and inset in c). Other BrdU+ dividing cells were 
Nkx2.1− (open arrowheads, c). (d–f) In the VZ and SVZ of the Nkx2.1−/− MGE*, numerous precursors were 
BrdU+ (open arrowheads, f), but only few were mut-Nkx2.1+ (solid arrowheads and inset, f). (LGE), lateral 
ganglionic eminence; (MGE), medial ganglionic eminence; (MGE*) mutant MGE; (POA) preoptic area; (SVZ) 
subventricular zone; (TS) triangular septal nucleus; (VZ) ventricular zone. Bar = 675 μ m in (a) and (d); 100 μ m  
in (b) and (c); 45 μ m in (c) and (d). (g–j) Bars (mean ± SEM from n = 4 Ctl and Nkx2.1−/− brains each) represent 
the percentage of the BrdU+ cells (g); the percentage of Nkx2.1+ or mut-Nkx2.1+ dividing cells amongst the 
total BrdU+ cells (h); the percentage of BrdU+ cells amongst the total Nkx2.1+ or mut-Nkx2.1+ cells (i), and 
the percentage of Nkx2.1− cells co-stained for BrdU (j) in Ctl and Nkx2.1−/− regions at E16.5. (g) A significant 
decrease of BrdU+ precursors in MGE* was balanced by a significant increase in BrdU+ precursors in POA* of 
Nkx2.1−/− mice; (h) a drastic and significant decrease in the mut-Nkx2.1+ dividing cells in all Nkx2.1−/− regions; 
(i) the mut-Nkx2.1+ cells lost their capacity to divide in the MGE*, striatum and SVZ-POA*; (j) mut-Nkx2.1− 
cells still divided normally in the MGE* and POA* of Nkx2.1−/− mice. (g–j) Corresponding p-values for all the 
quantifications are indicate within text describing the results (***p < 0.001; **p < 0.01; *p < 0.05; Student’s t-test).
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Figure 8. Nkx2.1+ MGE and POA stem cells do not differentiate into astrocytes after Nkx2.1 inactivation. 
Double immunocytochemistry with: Nkx2.1 and GFAP (a and b) or with: Nkx2.1 and GLAST (c) on MGE-derived 
neurospheres from E14.5 Nkx2.1+/+ or Nkx2.1+/− control (Ctl) mice (n = 8) after 7 days in vitro (DIV). Double 
immunocytochemistry for mut-Nkx2.1 and GFAP (d and e) or for mut-Nkx2.1 and GLAST on MGE*-derived 
neurospheres from E14.5 Nkx2.1−/− mice (n = 6) after 7 days DIV. Cell nuclei were counterstained in blue with 
Hoechst (a–f). (b) and (e) are higher magnifications of the regions seen in a and d respectively. In neurospheres 
derived from control MGE, numerous GFAP+ and GLAST+ astrocytes were labeled with Nkx2.1 (solid arrowheads 
in b and c), while others were not (open arrowheads in b and c). In contrast in neurospheres derived from 
Nkx2.1−/− MGE*, GFAP+ and GLAST+ astrocytes were never observed to be co-labeled with mut-Nkx2.1 (open 
arrowheads in e and f), but neuronal cells still express the mutated Nkx2.1 protein (arrows in e). Bar = 675 μ m 
in a and d, and 50 μ m in b,c,e and f. (g) Bars represent the percentage of GFAP+ or GLAST+ astrocytes labeled 
with Nkx2.1 in MGE– or POA–derived neurospheres from Ctl and of GFAP+ or GLAST+ astrocytes labeled with 
mutated Nkx2.1 in MGE*–derived neurospheres from Nkx2.1−/− mice brains (mean ± SEM from a sample of 
n = 21 MGE, n = 34 POA Ctl neurospheres and n = 22 MGE*, n = 28 POA* Nkx2.1−/− neurospheres for GFAP 
staining; mean ± SEM from a sample of n = 5 MGE Ctl neurospheres and n = 3 MGE* Nkx2.1−/− neurospheres 
for GLAST staining). Neurospheres originating from Nkx2.1−/− MGE* and POA* practically lost the capacity to 
produce Nkx2.1-derived astrocytes (p-value < 0.0001 for both). (***p < 0.001, Student’s t-test).
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(p-value < 0.0001 in the MGE* and POA* neurospheres in Fig. 8g). While more than 50% of differentiated 
GFAP+ and GLAST+ astroglia expressed Nkx2.1 in control neurospheres, less than 10% of GFAP+ and GLAST+ 
astroglia expressed mut-Nkx2.1 in mutant neurospheres (Fig. 8g) indicating that in mutant MGE* and POA* 
neurospheres mut-Nkx2.1+ precursors have mainly lost their capacity to generate astroglia.
Nkx2.1 directly regulates the expression of GFAP. From our results, astroglial cell populations of the 
embryonic telencephalon are derived from Nkx2.1+ progenitors and Nkx2.1 regulates astrocyte precursor cell 
proliferation. We looked if the transcription factor Nkx2.1 binds to the promoter of the GFAP gene expressed 
in some brain astroglia and regulates its expression. Chromatin immunoprecipitation assays were performed on 
lysates of E16.5 embryonic brains. First we looked for DNA elements in the GFAP gene promoter and of a nega-
tive control gene, Neurog2 that regulates dorsal precursors matching the consensus NK2 family binding sequence 
[GNNCACT(T/C)AAGT(A/G)(G/C)TT]35,57. Since a complete consensus binding sequence was not found, the 
core binding sequence T(C/T)AAG was chosen for analysis. As positive control, we used Lhx6 (LIM homeodo-
main gene) for which the binding site of Nkx2.1 is already known58. Then, after shortlisting the position of puta-
tive Nkx2.1 binding sites, primers for the flanking sequences of all shortlisted binding sites (up to three) were 
made (see methods and Supp. Fig. S5A). We performed PCR on cross-linked and sonicated DNA pulled down 
using an anti-Nkx2.1 monoclonal antibody. The amplification of a putative Nkx2.1 binding sequence located 
within the GFAP gene (Fig. 9a) was found in the chromatin immunoprecipitated with the Nkx2.1 antibody, how-
ever, no positive interaction was detected for Neurog2 (Fig. 9c). Amplification of the already known Nkx2.1 bind-
ing site within the Lhx6 promoter was positive after immunoprecipitation with the anti-Nkx2.1 antibody (Fig. 9b). 
Furthermore, the PCR fragment(s) amplified in the GFAP promoter contained the core sequence CTCAAGT of 
the Nkx2.1 consensus binding sequence. This suggests that in vivo, Nkx2.1 binds to the promoter region of the 
astroglial GFAP regulatory gene at the highly conserved core-binding sequence of the consensus-binding site.
To investigate the influence of the binding of Nkx2.1 to this promoter sequence on the transcription of GFAP 
gene, we performed co-transfection studies in HEK293 cells. We used the expression plasmid pDRIVE-mGFAP, 
which contains the LacZ reporter under the control of the upstream − 1679 bp mouse GFAP promoter 
sequence (that includes the putative Nkx2.1 binding site; Supp. Fig. S5B). This was co-transfected with the 
pCAG-Nkx2.1-IRES-Tomato plasmid that constitutively over-expresses Nkx2.1 and Tomato proteins under 
the control of the pCAG promoter. Co-transfection in HEK293 cells resulted in robust expression of the LacZ 
reporter (98% of Tomato+ cells were LacZ+, n = 50; Fig. 9g–i). Conversely, almost no expression was seen with 
co-transfection of the pDRIVE-mGFAP plasmid with a control pCAG-IRES-Tomato plasmid lacking the Nkx2.1 
cDNA (only 4.26% of Tomato+ cells were LacZ+, n = 94; Fig. 9d–f). This suggests that activation of the GFAP 
promoter fragment requires the presence of Nkx2.1, which probably acts at the binding sequence we identified.
Overall, the results show that the Nkx2.1 homeobox gene regulates proliferation of astroglia that occupy the 
CC region during late embryonic stages.
Discussion
Nkx2.1 is implicated in the specification of GABAergic interneurons and oligodendrocytes that occupy the 
embryonic telecephalon3,16,37,41–43. Recently, our group has shown that Nkx2.1 controls the production of the 
GABAergic interneurons, astrocytes and NG2 glia that populate the embryonic ventral telencephalon18,44. In this 
study, we now show that Nkx2.1 regulates the generation of the dorsal astroglia that populate the corpus callosum 
and its surrounding regions at late embryonic stages. Nkx2.1 controls astroglia by regulation of the proliferative 
capacity of Nkx2.1+ precursors present in the ventral progenitor regions, namely the MGE, the AEP/POA and 
the TS. By controlling the production of neurons and glia that populate the entire telencephalon, Nkx2.1 is a key 
factor for brain patterning in embryonic development.
Origins and timing of gliogenesis in mouse brain. The exact timing of the generation and origin of 
embryonic glia is a topic of active investigation. Several mechanisms describing spatial and temporal differen-
tiation of progenitors required for generation of the correct number of different types of glial cells have been 
proposed. Radial glia (RG) stem cells of the ventricular zone are proposed as the principal progenitor type during 
late embryonic brain development. During embryonic development, RG cells of the dorsal telencephalon not only 
generate most neurons of the cerebral cortex but also give rise later to two main glial sub-types, astrocytes and 
oligodendrocytes19,22,23,26,29. This hypothesis is supported by the generation of astrocytes and oligodendrocytes 
by spinal cord radial precursors59. Embryonic astroglia of the CC and the IG are also believed to originate from 
the radial glia of the dorsomedial pallium30,31. Contrary to what has been so far proposed, our study here shows 
for the first time that Nkx2.1 regulates the generation of transient midline dorsal embryonic astroglia of the CC 
and IG from the ventral progenitor regions. This is in accordance with our previous work showing that transient 
embryonic astroglia of the ventral telencephalon and transient embryonic NG2 glia occupying ventral and dorsal 
telencephalic regions are both derived from Nkx2.1+ progenitors from the subpallium18,44. Numerous studies also 
indicate that embryonic oligodendrocytes are produced in waves from the ventral telencephalic progenitors16,17. 
Additionally, subpopulations of telencephalic NG2 glia are documented to originate from ventral radial glia and 
pallial progenitors at E1460,61. Also, previous reports have shown that some postnatal astrocytes occupying the 
cerebral cortex, white matter and striatum originate from progenitor cells in the subventricular zone (SVZ) of 
the mammalian forebrain33. Recent evidence, however, shows that local populations of differentiated astrocytes 
constitute the primary source of postnatal glia and the SVZ progenitors contribute to only 3% of postnatal glia34.
The temporal competence of glial progenitors is not yet fully known. In the dorsal telencephalon, astrocyte 
gliogenesis was reported to occur only after neurogenesis (after E17 in mice) when the bipotential radial glial cells 
of the dorsal pallium differentiate into astrocytes20–22,24,25,27–29. The time of generation of some of the astrocytes 
occupying the CC midline region however is noted to be between E13 and postnatal day 2 (P2) with a peak at 
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Figure 9. Binding of Nkx2.1 to conserved binding sequences in the promoters of various glial regulatory genes. 
Amplification of the putative Nkx2.1 binding sequences located in a 206 bp PCR product within the GFAP promoter 
(a) and in a 391 bp PCR fragment from the Lhx6 promoter (b) after chromatin immunoprecipitation (ChIP) with 
the Nkx2.1 antibody. Input DNA was added as the positive control as it contains the cross-linked sonicated genomic 
DNA taken before ChIP with the Nkx2.1 antibody; a strong signal was observed for all the promoter regions. No 
amplification of the Nkx2.1 core sequence (tcaag) located in two, 410 bp and 352 bp, PCR products from the Ngn2 
promoter was detected (c). No signal was detected in the negative control where no antibody was added for ChIP 
nor when no DNA was added while performing the PCR (a–c). A very faint signal was detected in some samples 
immunoprecipitated with non-specific control IgG. These results suggest that Nkx2.1 binds in vivo to the promoter 
region of GFAP at putative Nkx2.1 binding sequences. The relative intensities of all the bands were calculated by 
assigning an arbitrary value of 1 to the input band. The quantifications are indicated below the gels. The Figure 
represents one of three independently performed assays. As a control, human embryonic kidney 293 (HEK293) cells 
were co-transfected with two reporter-constructs, namely, the pDRIVE-mGFAP-LacZ and the pCAG-IRES-Tomato 
plasmids (d–f). Cell nuclei were counterstained in blue with Hoechst (d). In the control, only 4.26% of Tomato+cells 
were LacZ+, n = 94. To test the binding of Nkx2.1 to the GFAP promoter, HEK293 cells were co-transfected with two 
reporter constructs, namely, the pDRIVE-mGFAP-LacZ and the pCAG-Nkx2.1-IRES-Tomato plasmids (g–i). Cell 
nuclei were counterstained in blue with Hoechst (g). Activation of the LacZ reporter was seen upon addition of the 
Nkx2.1 expression vector, thus confirming that Nkx2.1 activates the GFAP promoter, most probably by binding the 
sequence identified as Nkx2.1 consensus. Here, 98% of Tomato+cells were LacZ+, n = 50. Bar = 50 μ m.
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E14, much earlier than previously proposed30. Our previous work demonstrated that transient Nkx2.1-derived 
midline glia in the anterior commissure region are already generated by E14.518. Here, we confirmed that tran-
sient Nkx2.1-derived astroglia in the CC and surrounding region are mainly generated between E14.5 to E16.5 
too. Contrary to previous reports, we show that not only are these glia generated much earlier than previously 
proposed but also that they are generated from the ventral Nkx2.1+ progenitor regions. Hence, our study here 
sheds light upon both the spatial and temporal aspects of origin of embryonic telencephalic glia.
Multilevel regulation of embryonic astrogliogenesis by Nkx2.1. The Nkx2.1-derived embryonic 
cell population is broadly divided into GABAergic neurons, astrocytes and NG2 glia based on their expression 
profiles. Only Nkx2.1+ astrocyte-like cells that are GLAST+ and/or GFAP+ maintain Nkx2.1 expression while 
other Nkx2.1-derived cells that are Olig2+ NG2 glia no longer express Nkx2.1 after differentiation. Loss of Nkx2.1 
function leads to a drastic reduction in the numbers of astroglia and NG2 glia in the midline dorsal (CC, IG, 
MZG) and ventral telencephalic (mutant MGE* and POA*, and septum) regions. The loss of astroglia and NG2 
glia is not accompanied by an increase in apoptotic cells indicating that loss is likely due to incapacity of the pre-
cursors to generate astroglia and NG2 glia. Indeed, further analyses revealed that the loss of glia is associated with 
a decrease in Nkx2.1-derived precursor division capacity. Accordingly, we observed a drastic decrease in GLAST+ 
precursors expressing the mut-Nkx2.1 in the VZ, SVZ of the mutant MGE*, mutant POA* and TS region, and in 
GLAST+ differentiated astrocytes expressing the mut-Nkx2.1 in the parenchyma (striatum, LPOA/LH, septum) 
in Nkx2.1−/− compared to mice. The decreased presence of the precursors and differentiated astroglial popu-
lation was accompanied by reduced proliferative status of the BrdU+ dividing cells containing mut-Nkx2.1 in 
the VZ and SVZ of mutant MGE*, mutant POA* and the septal nucleus region in Nkx2.1−/− mice compared to 
control precursors. Additionally, in vitro differentiation of E14.5 Nkx2.1−/− mutant MGE*, POA*-derived neuro-
spheres revealed that progenitors were unable to generate GFAP+ astroglia expressing mut-Nkx2.1 though they 
still retained the capacity to generate post-mitotic neurons. Hence, the reduction in number of astroglia and NG2 
glia can be attributed to inadequate proliferation of precursors in the three subpallial domains in the absence of 
Nkx2.1. Nonetheless, reduced generation of astroglia in the neurosphere assay could be due to decreased speci-
fication or differentiation capacity of precursors not expressing Nkx2.1. Evidence for this comes from previously 
published studies where loss of Nkx2.1 results in a ventral to dorsal re-specification of the MGE* to LGE*37. 
Likewise, we showed that in Nkx2.1-Cre+; Rosa-DTA mice, there is significant loss of differentiated astroglia at 
the anterior commissure midline without reduced precursor proliferation, thus, suggesting a role for Nkx2.1 after 
the proliferation step18. Nkx2.1-Cre+; Rosa-DTA mice cause the selective ablation of Nkx2.1-derived post-mitotic 
cells but not Nkx2.1+precursors due to a delay in expression and subsequent action of diphtheria toxin18. Also, the 
GLAST+ astroglia at the CC midline at E16.5-E18.5 still retain Nkx2.1 expression (Fig. 1c,d), pointing towards 
additional Nkx2.1 functions in mature astroglia. Performing a clonal analysis with the neurosphere assay where 
both the number and size of the astrocytic clones are estimated could provide further insights into Nkx2.1’s mode 
of action.
Chromatin immunopreciptation analysis performed in this study suggests that the Nkx2.1 might act by 
directly activating astroglial specific gene, such as GFAP as shown here. Future experiments where the putative 
Nkx2.1-binding site found in this study is mutated would further strengthen this result.
Thus, Nkx2.1 regulates the generation of dorsal telencephalic astroglia through multilevel controls that pos-
sibly involve mediating: (i) proliferation of Nkx2.1+ precursors, (ii) specification/differentiation of Nkx2.1+ pre-
cursors and (iii) transcriptional regulation of an astroglial gene.
Nkx2.1 is important for several aspects of brain development in embryogenesis. In Nkx2.1 
knockout mice several developmental abnormalities occur in the ventral forebrain43. Previous reports from our 
and other groups have shown that Nkx2.1 is not only important for regional specification of the ventral telen-
cephalic regions, MGE and POA, but is also essential for the generation of a wide spectrum of Nkx2.1-derived 
lineages, including GABAergic interneurons, NG2 glia (or oligodendrocytes) and astrocytes that populate both 
the dorsal and ventral telencephalon from E12.53,14,16–18,37,42–44,54,58,62–64. We showed previously that the absence 
of NG2 glia drastically affects the vascular development in all the telencephalon leading to severe blood vessels 
reduction of ramifications and connections44. We also demonstrated that a drastic reduction in Nkx2.1-derived 
cell populations leads to AC commissure agenesis and commissural axon misrouting18. Interestingly, the timing 
of generation of the Nkx2.1-derived cells precedes the arrival of the commissural axons at the AC midline, and 
some of the precursors in the TS and astrocytes surrounding the AC use Slit2 to tunnel the axons through the 
anterior commissure18.
Also, the reduced GABAergic neuronal population and possibly the loss of astrocytes in the Nkx2.1−/− mice 
lead to slight callosal axon branching and outgrowth defects in the CC tract65. Though Nkx2.1−/− mice display a 
drastic loss of astroglia within CC and its surrounding regions including IG and MZG, the mice do not present 
CC agenesis and severe callosal axon bundles defects. Hence, these results show that these astroglia do not play 
a major role in CC axon guidance. These results contradict previously published reports where IG astroglia have 
been proposed to act as guidepost cells for callosal axons31,66. However, we cannot exclude the proposed contribu-
tion of GW radial glia in callosal axon guidance66–68 since they are not Nkx2.1-derived and hence, are not ablated 
in Nkx2.1−/− mice. Thus, radial glia precursors occupying the GW and secreting Slit2 may be key player cells for 
callosal axon guidance during embryonic development.
Altogether, Nkx2.1 is able to perform its vast range of roles through regulation of proliferation of Nkx2.1+ 
precursors as shown here, and also possibly through an effect on glial specification/differentiation and survival. 
It appears that Nkx2.1 mediates part of these effects through transcriptional regulation, such as that shown for 
astroglial gene GFAP here. Interestingly, Nkx2.1 has previously been proposed to regulate several transcriptional 
programs that are important in vertebrate lung morphogenesis69. Notably, transcriptional regulation by Nkx2.1 
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in early (E11.5) and late (E19.5) mouse lung development40. Interestingly, in mouse lungs, Nkx2.1 also directly 
regulates cell cycle effectors and its loss alters cell cycle progression40. Further investigation into the complete 
repertoire of transcriptional regulation exerted by Nkx2.1 could provide interesting insights into Nkx2.1 mode of 
action and astroglial generation in the brain.
Along the same line, previous reports have shown that Nkx2.1 regulates the transcription of many 
thyroid-specific genes35–37 and activates pulmonary-surfactant38, as well as pituitary gland genes39. Moreover, 
it has been shown in vitro, that Nestin might be a target of Nkx2.170. Hence, it is probable that Nkx2.1 displays 
functional conservation in brain, thyroid, pituitary, and lung.
Complex cellular and molecular interactions between glia, neurons and guidance cues produced by them, 
govern the formation of the midline structures such as the corpus callosum and anterior commissure. Several 
Nkx2.1-derived glial and neuronal populations populate these structures, and further understanding of the mode 
of regulation mediated by Nkx2.1 can help to understand the formation of dorsal and ventral telencephalic regions.
Methods
Animals. All studies on mice of either sex were performed in compliance with the national and international 
guidelines, and with the approval of the Federation of Swiss cantonal Veterinary Officers (authorization number 
2164). Mice were housed under conditions of controlled temperature and illumination (12-hour light-dark cycle, 
with lights on at 07:00 am and off at 07:00 pm). Animals had ad libitum access to food and water and were moni-
tored regularly. For staging of embryos, midday of the day of vaginal plug formation was considered as embryonic 
day 0.5 (E0.5). Wild-type mice maintained in a CD-1/SWISS genetic background were used for developmental 
analysis of the CC. We used wild-type (+ /+ ) and homozygous mutant Nkx2.1 mice37,43,71, which are referred as 
Nkx2.1+/+ and Nkx2.1−/− respectively, in this work. We used heterozygous GAD67-GFP knock-in mice, described 
as Gad1-EGFP knock-in mice53. Gad1-EGFP knock-in embryos can be recognized by their GFP fluorescence. 
PCR genotyping of these lines was performed as described previously72. We used GLAST-Cre ERTTM (purchased 
from Jackson Laboratory: Tg(Slc1a3-cre/ERT)1Nat/J) transgenic mice that have a tamoxifen-inducible Cre 
recombinase fused to the ligand binding domain of the estrogen receptor under the control of the Slc1a3 (solute 
carrier family 1 (glial high affinity glutamate transporter; GLAST) promoter. We used Nkx2.1-cre64 and Cspg4-cre 
(Jackson Laboratory: B6;FVB-Tg(Cspg4-cre)1Akik/J)51 transgenic mice that have been described previously. The 
reporter mouse Rosa26R–Enhanced yellow fluorescent protein (EYFP)73 was used to reliably express EYFP under 
the control of the Rosa26 promoter upon Cre-mediated recombination.
For the induction of CreERT, Tamoxifen (20 mg/ml, Sigma, St Louis, MO) was dissolved at 37 °C in 5 ml corn 
oil (Sigma, St Louis, MO) pre-heated to 42 °C for 30 minutes. A single dose of 4 mg (250–300 μ l) was administered 
to pregnant females at E14.5 by oral gavaging.
Immunocytochemistry. Embryos were collected after caesarean section and quickly killed by decapitation. 
Their brains were dissected out and fixed by immersion overnight in a solution of 4% paraformaldehyde in 0.1 M 
phosphate buffer (pH 7.4) at 4 °C. Brains were cryoprotected in a solution of 30% sucrose in 0.1 M phosphate 
buffer (pH 7.4), frozen and cut as 50 μ m-thick coronal sections for immunostaining.
Mouse monoclonal antibodies were: BrdU (1/50; Monosan), Nestin (1/600; Pharmingen) and GFAP (1/500; 
Chemicon). Rat monoclonal antibody was: L1 (1/200; Chemicon). Rabbit polyclonal antibodies were: Calretinin 
(1/2000; Swant); GFAP (1/500; DAKO); GFP (1/500; Molecular Probes); NG2 (1/100; Chemicon); Nkx2.1 
(1/2000; Biopat); Olig2 (1/500; Millipore); RFP (1/500; Labforce) and S100ß (1/2500; Swant). Guinea pig antibody 
was: GLAST (1/200; Chemicon). Chicken antibody was: GFP (1/500; Aves).
Fluorescence immunostaining was performed as follows: non-specific binding was blocked with 2% normal 
horse serum in PBS 1X solution with 0.3% Triton X-100 for preincubation and incubations. The primary antibod-
ies were detected with Cy3-conjugated (Jackson ImmunoResearch laboratories, West Grove, PA) and Alexa488-, 
Alexa594- or Alexa647-conjugated antibodies (Molecular Probes, Eugene, OR) used at 1:300 dilution. Sections 
were counterstained with Hoechst 33258 (Molecular Probes), mounted on glass slides and covered in Mowiol 
4-88 (Calbiochem, Bad Soden, Germany).
DAB immunostaining was performed as follows: Endogenous peroxidase reaction was quenched with 0.5% 
hydrogen peroxide in methanol and non-specific binding was blocked by adding 2% normal horse serum in 
Tris-buffered solutions containing 0.3% Triton X-100 for preincubation and incubations. The primary antibod-
ies were detected with biotinylated secondary antibodies (Jackson ImmunoResearch, West Grove, PA) and the 
Vector-Elite ABC kit (Vector Laboratories, Burlingame, CA). The slices were mounted on glass slides, dried, 
dehydrated, and covered with Eukitt.
BrdU tracing studies. To label cells in the S-phase of the cell cycle at the suitable embryonic stages (E12.5, 
E14.5 and E16.5), pregnant female mice were injected intraperitoneally with a solution of 8 mg/ml of 5-bromo-2′ - 
deoxyuridine (BrdU; Sigma, St Louis, MO) in PBS (0.15 M NaCl, 0.1 M phosphate buffer, pH = 7.4) at a final 
concentration of 50 mg/kg body weight. To trace the division rate of the subpallial precursors, pregnant females 
were sacrificed 1-2 hours post-injection. To trace the date of genesis of the CC astrocytes, pregnant females were 
sacrificed when embryos were E18.5. BrdU was revealed by DAB or fluorescence immunostaining (as above) after 
a treatment with 2 M HCl for 30 min at room temperature.
Imaging. DAB stained sections were imaged with a Zeiss Axioplan2 microscope equipped with 10× , 
20× or 40× Plan neofluar objectives and coupled to a CCD camera (Axiocam MRc 1388 × 1040 pixels). 
Fluorescent-immunostained sections were imaged using confocal microscopes (Zeiss LSM 510 Meta, Leica SP5 
or Zeiss LSM 710 Quasar) equipped with 10× , 20× , 40× oil Plan neofluar and 63 × oil, 100× oil Plan apochromat 
objectives. Fluorophore excitation and scanning were done with an Argon laser 458, 488, 514 nm (blue excitation 
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for GFP and Alexa488), with a HeNe laser 543 nm (green excitation for Alexa 594 and CY3), with a HeNe laser 
633 nm (excitation for Alexa 647 and CY5) and a Diode laser 405 nm (for Hoechst-stained sections). Z-stacks of 
10–15 planes were acquired for each CC coronal section in a multitrack mode avoiding crosstalk.
All 3D Z stack reconstructions and image processing were performed with Imaris 7.2.1 software. To create real 
3D data sets, we used the mode “Surpass”. The colocalization between two fluorochromes was calculated and vis-
ualized by creating a yellow channel. Figures were processed in Adobe Photoshop© CS4 and CS5 and schematic 
illustrations in Fig. 2 were produced using Adobe Illustrator© CS4.
In vivo Quantifications. Glial cell population analysis. In 50 μ m thick brain sections of Nkx2.1+/+ and 
Nkx2.1−/− embryos at E18.5, the astroglial cells were labeled with GFAP and polydendroglial cells were labeled 
with NG2. Cells were counted in the CC, IG, MGE, MZG and POA regions from at least 4 brains per condition. 
Cell densities were reported per surface unit area (number of cells/mm2). The quantification was done using 
Neurolucida 9.0 and Neurolucida 9.0 Explorer© software.
In 50 μ m thick brain sections of Nkx2.1+/+ and Nkx2.1−/− embryos at E18.5, the astroglial cells that were labe-
led for Olig2 or both Olig2 and GLAST were counted in the CC mid from at least 2 brains per condition. Olig2 
staining labeled the glial cell bodies while GLAST labeled both the cell bodies and processes. The cell densities 
were determined in the medial and lateral part of the CC. The cell densities were reported per volume unit (num-
ber of cells/mm3). The quantification was done using Imaris® 7.2.1 software.
Nkx2.1+ and GLAST+ and BrdU+ proliferation analyses. Pregnant female mice were injected intraperitoneally 
with a solution of 8 mg/ml of 5-bromo-2′ -deoxyuridine in PBS to a final concentration of 50 mg/kg body weight. 
To trace the division rate of the subpallial precursors, pregnant females were sacrificed 2 hours post-injection. 
Embryos were collected after caesarean section and quickly killed by decapitation. Their brains were dissected 
out and fixed by immersion overnight in a solution of 4% paraformaldehyde in 0.1 M phosphate buffer (pH 
7.4) at 4 °C. In 50 μ m thick brain sections of Nkx2.1+/+ and Nkx2.1−/− embryos at E16.5, Nkx2.1+ cells, BrdU+ 
dividing cells and GLAST+ precursors or post-mitotic astroglial cells of the MGE, POA and TS were counted 
in the VZ, SVZ and in the parenchyma of each region, from at least 4 brains per condition. Nkx2.1 and BrdU 
staining labeled the cell bodies while GLAST labeled both the cell bodies and processes. Although the expres-
sion level of truncated Nkx2.1 protein (mut-Nkx2.1) in Nkx2.1−/− embryos was low, it was easily identifiable 
using immunostaining and quantifications were performed on higher magnification images where the staining 
could be easily visualized. The percentage of Nkx2.1-derived dividing precursors or post-mitotic glial cells were 
determined as follows: In each sub region and for each condition, a sample of at least four different Z-stacks 
was acquired at 100x magnification using a Leica SP5 confocal microscope. The Z-stacks comprised 10 planes 
that were acquired in a multitrack mode avoiding any crosstalk. Thereafter, in order to exclude the possibility 
of quantifying the same cells more than once, snapshots of only 3 planes (from the acquired 10 planes), were 
analyzed. The quantification of Nkx2.1, BrdU, GLAST and Hoechst staining was done on each snapshot sepa-
rately Imaris® 7.2.1 software.
Cell death analysis. In brain sections of Nkx2.1+/+ and Nkx2.1−/− embryos at E16.5, apoptotic cells labeled 
with either cleaved-caspase 3 or TUNEL were counted in the CC, MGE, SEP, and POA from at least 2 brains 
per condition. 50 μ m thick brain sections were used for cleaved-caspase 3 staining whereas 10 μ m thick brain 
sections were utilized for TUNEL staining. Cell nuclei were counterstained with Hoechst. For each condition, 
at least 5 different Z-stacks were obtained at 100x magnification using a Leica SP5 microscope. The number 
of apoptotic nuclei were counted and reported as an absolute number per section (the surface area of one sec-
tion was 24119.332 μ m2). The quantification was done using Neurolucida 9.0 and Neurolucida 9.0 Explorer© 
software.
Neurosphere generation and microscopic analysis. The protocol has been adapted from Arsenijevic 
et al., 2001.
Primary culture and sphere passaging. The brains of embryos at developmental stage E14.5 were collected as 
described above. They were carefully removed from the skull into ice-cold sterile dissecting medium (MEM 
1X) complemented with Glucose 1 M (5 ml/100 ml). Thereafter, the brains were embedded in low melting point 
Agarose 3% (LMP-Agar, Gibco) at 37 °C, and cut into 250 μ m thick slices using a vibratome (Leica© VT 1000 S). 
The sections were collected in the ice-cold dissecting medium. The areas of interest (MGE, POA and SEP) were 
dissected out using two tungsten needles under a stereomicroscope (Leica© MZ16F). The dissected pieces of tis-
sue were then collected into 1 ml ice-cold sterile Hormone Mix Medium (MHM 1X) supplemented with Penicillin 
(50 U/ml) and Streptomycin (50 U/ml) (GIBCO). The Hormone Mix Medium is a growing medium containing 
DMEM and F-12 nutrient (1:1), glucose (0.6%), glutamine (2 mM), sodium bicarbonate (3 mM), HEPES buffer 
(5 mM), transferrin (100 mg/ml), insulin (25 μ g/ml), progesterone (20 nM), putrescine (60 μ M), selenium chlo-
ride (30 nM)74. Brain tissue pieces were mechanically dissociated in sterile conditions with a fire-polished pipette 
in the Hormone Mix Medium. The pipette was rinsed before the dissociation of each new region.
The dissociated cells were then grown in Hormone Mix Medium complemented with Pen/Strep and EGF in 
6-well dishes (Nunclon Surface, NUNC Brand Products, Nalge Nunc International) at a concentration of around 
104–105 cells per 1 ml and 4 ml per dish. After 6-7 days in vitro (DIV) at 37 °C in a 5% CO2 atmosphere, the sphere 
cultures were expanded. Primary spheres were dissociated mechanically and cells were plated at the density of 
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2 × 106 cells for 40 ml in a flask (Nunclon Surface, NUNC Brand Products, Nalge Nunc International). Sphere 
passages were done every 7 DIV, by sphere dissociation and transfer of 2 × 106 cells to a new 40 ml flask.
Differentiation of spheres. After 7 DIV, the neurospheres of optimum size were chosen under a steremicro-
scope (Nikon©) and transferred individually and plated onto poly-L-ornithine coated coverslips in 24-well plates 
(Nunclon Surface, NUNC Brand Products, Nalge Nunc International). Each coverslip contained about ten spheres 
and 1 ml of Hormone Mix Medium supplemented with Pen/Strep and 2% fetal bovine serum (FBS).
Immunofluorescence on differrentiated Neurospheres. After 7 DIV, the neurospheres were fixed in 4% PFA for 
20 minutes and permeabilized with 0.3% triton/PBS1X for 3 minutes. Coverslips were incubated with primary anti-
bodies diluted in PBS containing 10% NHS for 2 hours at room temperature, followed by secondary fluorescent 
antibodies for 45 minutes at 37° and Hoechst staining for 5 minutes.
Neurosphere production analysis. MGE- and POA-derived neurospheres were obtained from Nkx2.1+/+ and 
Nkx2.1−/− E14.5 embryos. After 7 DIV, the neurospheres were differentiated and immunostained as mentioned 
above. Two different brains were used for each condition and were labeled for Nkx2.1, GFAP, GLAST, and β III 
tubulin. Cell nuclei were counterstained with Hoechst. For each condition, a total of at least 5 different Z-stacks 
in 5 different neurospheres were acquired at 100x magnification using a Leica SP5 microscope. The percentage of 
Nkx2.1+/GFAP+ differentiated astrocytes and Nkx2.1+/β III tubulin+ differentiated neurons were counted directly 
on the Z-stacks by using Imaris® 7.2.1 software.
Chromatin Immunoprecipitation. Chromatin immunoprecipitation was conducted on E16.5 brain sam-
ples according to the instructions provided by the manufacturer (Upstate, 17-295), using 2 μ g of mouse anti-Nkx2.1 
monoclonal antibody (MS699-P, Lab Vision). For crosslinking, 1% PFA was used. For sonication, six bursts of 45 sec-
onds ON (30% power) and 30 second OFF were given and samples were kept on ice throughout. Mouse Genome 
Assembly data mm9 was used to map sites.
A 391 bp PCR fragment of the Lhx6 promoter that includes a Nkx2.1 binding sequence at position − 240 bp 
relative to the putative transcriptional start site was identified using primers 5′ -tttgtaccgagagtaggagaagg and 5′ - 
gtcctaactttgtagtgggcattt.
A 206 bp PCR fragment of the GFAP promoter that includes a putative Nkx2.1 binding sequence (ctcaagt) at 
position − 838 bp relative to the putative transcriptional start site was found to be a binding target and was identified 
using primers 5′ - tggataagaggccacagagg and 5′ - cctctcccctgaatctctcc.
Primers against two fragments of the Neurogenin2 promoter region, comprising the core Nkx2.1 binding 
consensus sequence (tcaag), were made. 1) Primers 5′ -cgggattctgactctcactaattc and 5′ -aatggttctaaagctcctgttgg 
were designed to amplify a 410 bp PCR fragment with the core consensus Nkx2.1 binding sequence at posi-
tion − 668 bp relative to the putative transcriptional start site. 2) Primers 5′ -cgggattctgactctcactaattc and 5′ - 
aatggttctaaagctcctgttgg were designed to amplify another 352 bp PCR fragment with the core consensus Nkx2.1 
binding sequence at position − 4073 bp relative to the putative transcriptional start site.
Following controls were used: (1) Null – beads only without any antibody, (2) IgG – beads with an isotype 
matched control immunoglobulin (Ig) to know the background of the assay, (3) Input – starting material taken 
before immunoprecipitation with antibody, and (4) Negative – non-template control used for the PCR reaction to 
spot any contamination.
For quantification, ImageJ was used to measure the band densities (https://imagej.nih.gov/ij/docs/menus/
analyze.html#gels). The relative intensities of all the bands (null control, IgG control, immunoprecipitated with 
antibody, and negative control) were calculated by assigning an arbitrary value of 1 to the input band.
Transfection of HEK293 cells. A suspension of HEK293 cells adapted to serum-free growth medium 
was plated at 1 × 106 cells in 4 ml media in a 60mm plate. For formation of the transfection complexes, a 3:1 
ratio of FuGENE® HD Transfection Reagent (μ l): plasmid DNA (μ g) was prepared and used for transfection. 
The study was performed by co-transfecting an expression plasmid for constitutive over-expression of Nkx2.1 
(pCAG-Nkx2.1-IRES-Tomato) or a control plasmid (pCAG-IRES-Tomato) with the pDRIVE-mGFAP plasmid con-
taining the GFAP promoter region in front of the LacZ reporter gene. The pCAG promoter is constructed of follow-
ing sequences: (C) cytomegalovirus early enhancer element, (A) promoter, the first exon and intron of the chicken 
beta-actin gene and (G) the splice acceptor of the rabbit beta-globin gene. The mouse GFAP promoter sequence 
from the pDRIVE-mGFAP plasmid (#pdrive-mgfap, InvivoGen) used for transfection experiments is shown in 
Supp. Fig. S5B. Transfection complexes were formed by mixing 2 μ g of each of the two plasmids with 12 μ l of Fugene 
transfection reagent and 188 μ l of Optimem reduced serum media. The mix was incubated at room temperature for 
20 minutes and then added to the cell plates. The cell plates were kept in the 37 °C incubator and gene expression 
analysis was done after 24–48 hours of transfection. Fluorescence immunostaining was done to visualize the pres-
ence and level of LacZ expression. Tomato signal was visible by direct fluorescence, however, for a clearer visualiza-
tion of Tomato signal anti-RFP immunostaining was done (described above).
Experimental design and statistical analysis. For all analyses at least three independent experi-
ments were performed. Mutant embryos were always compared with controls originating from the same litter. 
Qualitative, morphological and cellular change phenotypes of the control and mutant brains were ascertained 
blindly. Quantitative analyses were verified blindly by a second experimenter. The results from all quantifications 
were analyzed with the aid of Statview software (SAS Institute Inc.). For all analyses, values were first tested for 
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normality and the variance of independent populations were tested for equality. Values that followed a normal 
distribution were compared using Student’s t-test. To show the degree of significance for quantitation included 
in the study, we added the number of asterisks based on the following standard p-value criteria: ***p < 0.001; 
**p < 0.01; *p < 0.05.
Atlas and nomenclature. The neuroanatomical nomenclature is based on the “Atlas of the prenatal mouse 
brain”75.
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